Figure 3.

(a–d): A 28-year-old male presented with a small JRCH in the left eye. His BCVA was No PL in the right eye and 20/20 in the left eye. He underwent three sittings of ICG-TTT with an intravitreal dexamethasone implant in the left eye at an interval of 2 months. At the last follow-up, the tumor showed regression with resolution of SRF and stabilization of vision. (e–h): A 24-year-old female was diagnosed to have left eye JRCH with presence of SRF and intraretinal fluid. Her BVCA was No PL in the right eye and 20/20 in the left eye. She was treated with one sitting of ICG-TTT, following which the tumor remained stable with resolution of SRF and stable vision